Pharmaust Limited (AU:PAA) has released an update.
Pharmaust Limited has filed a Final Director’s Interest Notice indicating that director John Clark ceased his directorship on May 31, 2024. The notice, required by the listing rules, reveals that Clark held 1,125,000 Performance Rights and 250,000 Unlisted Options expiring in January 2026, prior to his departure.
For further insights into AU:PAA stock, check out TipRanks’ Stock Analysis page.
